EMEA-001741-PIP06-18 - paediatric investigation plan
upadacitinib
PIPHuman
AbbVie Ltd
E-mail: paediatricteam@abbvie.com
Tel. +44 (0)1628 408248
P/0103/2019: EMA decision of 25 March 2019 on the granting of a product-specific waiver for upadacitinib (EMEA-001741-PIP06-18)